Media

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Date

January 6, 2018

Informing the tolerability of cancer treatments using patient-reported outcome (PRO) measures: summary of an FDA and Critical Path Institute workshop

January 6, 2018

Mycobacterial biomaterials and resources for researchers

January 6, 2018

Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study

January 1, 2018

Development of a symptom-focused patient-reported outcome measure for functional dyspepsia: the Functional Dyspepsia Symptom Diary (FDSD)

January 1, 2018

Performance Assessment of New Urinary Translational Safety Biomarkers of Drug-induced Renal Tubular Injury in Tenofovir-treated Cynomolgus Monkeys and Beagle Dogs

January 1, 2018

Individual serum bile acid profiling in rats aids in human risk assessment of drug-induced liver injury due to BSEP inhibition

December 22, 2017

Application of a Dynamic Map for Learning, Communicating, Navigating, and Improving Therapeutic Development

December 22, 2017

A Dynamic Map for Learning, Communicating, Navigating and Improving Therapeutic Development

December 22, 2017

Qualitative Development and Cognitive Evaluation of the Symptoms of Major Depressive Disorder (S-MDD), A Consortium-Developed Patient Reported Outcome Measure

December 18, 2017

C-Path receives COA qualification from FDA for the Symptoms of Major Depressive Disorder Scale (SMDDS)

Tucson, AZ – December 18, 2017 Critical Path Institute‘s (C-Path) Patient-Reported Outcome (PRO) Consortium annou

Previous8485 86...133 Next